By Mike Curley ( May 11, 2020, 1:55 PM EDT) -- A California appeals court has reinstated claims against Johnson & Johnson and its subsidiaries alleging the antipsychotic drug Risperdal causes gynecomastia, a condition that causes abnormal enlargement of breasts in males, saying the claims are not federally preempted as J&J failed to send all of its data to the FDA....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.